Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

118 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Anti-Virulence Properties of Plant Species: Correlation between In Vitro Activity and Efficacy in a Murine Model of Bacterial Infection.
Díaz-Núñez JL, Pérez-López M, Espinosa N, Campos-Hernández N, García-Contreras R, Díaz-Guerrero M, Cortes-López H, Vázquez-Sánchez M, Quezada H, Martínez-Vázquez M, Soto-Hernández RM, Burgos-Hernández M, González-Pedrajo B, Castillo-Juárez I. Díaz-Núñez JL, et al. Microorganisms. 2021 Nov 25;9(12):2424. doi: 10.3390/microorganisms9122424. Microorganisms. 2021. PMID: 34946027 Free PMC article.
Tetradecanoic Acids With Anti-Virulence Properties Increase the Pathogenicity of Pseudomonas aeruginosa in a Murine Cutaneous Infection Model.
Juárez-Rodríguez MM, Cortes-López H, García-Contreras R, González-Pedrajo B, Díaz-Guerrero M, Martínez-Vázquez M, Rivera-Chávez JA, Soto-Hernández RM, Castillo-Juárez I. Juárez-Rodríguez MM, et al. Front Cell Infect Microbiol. 2021 Jan 27;10:597517. doi: 10.3389/fcimb.2020.597517. eCollection 2020. Front Cell Infect Microbiol. 2021. PMID: 33585272 Free PMC article.
A Brominated Furanone Inhibits Pseudomonas aeruginosa Quorum Sensing and Type III Secretion, Attenuating Its Virulence in a Murine Cutaneous Abscess Model.
Muñoz-Cázares N, Castillo-Juárez I, García-Contreras R, Castro-Torres VA, Díaz-Guerrero M, Rodríguez-Zavala JS, Quezada H, González-Pedrajo B, Martínez-Vázquez M. Muñoz-Cázares N, et al. Biomedicines. 2022 Jul 31;10(8):1847. doi: 10.3390/biomedicines10081847. Biomedicines. 2022. PMID: 36009394 Free PMC article.
Editorial: Alternatives to Combat Bacterial Infections.
García-Contreras R, Martínez-Vázquez M, González-Pedrajo B, Castillo-Juárez I. García-Contreras R, et al. Front Microbiol. 2022 May 4;13:909866. doi: 10.3389/fmicb.2022.909866. eCollection 2022. Front Microbiol. 2022. PMID: 35602022 Free PMC article. No abstract available.
Repurposed anti-cancer drugs: the future for anti-infective therapy?
Quezada H, Martínez-Vázquez M, López-Jácome E, González-Pedrajo B, Andrade Á, Fernández-Presas AM, Tovar-García A, García-Contreras R. Quezada H, et al. Expert Rev Anti Infect Ther. 2020 Jul;18(7):609-612. doi: 10.1080/14787210.2020.1752665. Epub 2020 Apr 15. Expert Rev Anti Infect Ther. 2020. PMID: 32290720 No abstract available.
Repurposing of Anticancer Drugs for the Treatment of Bacterial Infections.
Soo VW, Kwan BW, Quezada H, Castillo-Juárez I, Pérez-Eretza B, García-Contreras SJ, Martínez-Vázquez M, Wood TK, García-Contreras R. Soo VW, et al. Curr Top Med Chem. 2017;17(10):1157-1176. doi: 10.2174/1568026616666160930131737. Curr Top Med Chem. 2017. PMID: 27697046 Review.
The race between drug introduction and appearance of microbial resistance. Current balance and alternative approaches.
López-Jácome E, Franco-Cendejas R, Quezada H, Morales-Espinosa R, Castillo-Juárez I, González-Pedrajo B, Fernández-Presas AM, Tovar-García A, Angarita-Zapata V, Licona-Limón P, Martínez-Vázquez M, García-Contreras R. López-Jácome E, et al. Curr Opin Pharmacol. 2019 Oct;48:48-56. doi: 10.1016/j.coph.2019.04.016. Epub 2019 May 26. Curr Opin Pharmacol. 2019. PMID: 31136908 Review.
118 results